Research Analysts’ Price Target Changes for April 30th (ABBV, ASH, BXMT, C, CFG, CG, CNMD, ETSY, EXLS, FITB)

Research Analysts’ price target changes for Thursday, April 30th:

AbbVie (NYSE:ABBV) had its target price boosted by Canaccord Genuity Group Inc. from $262.00 to $265.00. They currently have a buy rating on the stock.

Ashland (NYSE:ASH) had its target price cut by JPMorgan Chase & Co. from $70.00 to $65.00. The firm currently has an overweight rating on the stock.

Blackstone Mortgage Trust (NYSE:BXMT) had its target price trimmed by JPMorgan Chase & Co. from $21.00 to $20.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Citigroup (NYSE:C) had its price target raised by JPMorgan Chase & Co. from $131.00 to $135.50. They currently have an overweight rating on the stock.

Citizens Financial Group (NYSE:CFG) had its target price increased by JPMorgan Chase & Co. from $68.00 to $68.50. The firm currently has an overweight rating on the stock.

Carlyle Group (NASDAQ:CG) had its target price reduced by JPMorgan Chase & Co. from $67.00 to $66.00. The firm currently has a neutral rating on the stock.

CONMED (NYSE:CNMD) had its price target reduced by JPMorgan Chase & Co. from $43.00 to $40.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Etsy (NYSE:ETSY) had its target price increased by Canaccord Genuity Group Inc. from $72.00 to $80.00. They currently have a buy rating on the stock.

ExlService (NASDAQ:EXLS) had its target price raised by JPMorgan Chase & Co. from $42.00 to $43.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Fifth Third Bancorp (NASDAQ:FITB) had its price target raised by JPMorgan Chase & Co. from $53.00 to $54.50. The firm currently has an overweight rating on the stock.

General Dynamics (NYSE:GD) had its price target increased by JPMorgan Chase & Co. from $385.00 to $400.00. The firm currently has an overweight rating on the stock.

GE HealthCare Technologies (NASDAQ:GEHC) had its target price lowered by JPMorgan Chase & Co. from $80.00 to $65.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Glaukos (NYSE:GKOS) had its price target raised by JPMorgan Chase & Co. from $120.00 to $140.00. They currently have an overweight rating on the stock.

Generac (NYSE:GNRC) had its target price increased by JPMorgan Chase & Co. from $229.00 to $267.00. The firm currently has an overweight rating on the stock.

Huntington Bancshares (NASDAQ:HBAN) had its price target reduced by JPMorgan Chase & Co. from $19.00 to $18.50. The firm currently has an overweight rating on the stock.

LGI Homes (NASDAQ:LGIH) had its target price boosted by JPMorgan Chase & Co. from $38.00 to $41.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.

MediaAlpha (NYSE:MAX) had its target price boosted by JPMorgan Chase & Co. from $11.00 to $12.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

M&T Bank (NYSE:MTB) had its target price lowered by JPMorgan Chase & Co. from $231.50 to $227.00. They currently have a neutral rating on the stock.

Nutrien (NYSE:NTR) had its price target reduced by Canadian Imperial Bank of Commerce from $90.00 to $88.00. The firm currently has an outperformer rating on the stock.

The PNC Financial Services Group (NYSE:PNC) had its target price boosted by JPMorgan Chase & Co. from $237.50 to $238.00. They currently have an overweight rating on the stock.

Q2 (NYSE:QTWO) had its target price boosted by JPMorgan Chase & Co. from $75.00 to $80.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

uniQure (NASDAQ:QURE) had its price target boosted by Chardan Capital from $31.00 to $37.00. Chardan Capital currently has a buy rating on the stock.

Red Rock Resorts (NASDAQ:RRR) had its target price reduced by JPMorgan Chase & Co. from $73.00 to $66.00. The firm currently has an overweight rating on the stock.

Recursion Pharmaceuticals (NASDAQ:RXRX) had its price target lowered by JPMorgan Chase & Co. from $11.00 to $10.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Sprouts Farmers Market (NASDAQ:SFM) had its target price raised by JPMorgan Chase & Co. from $77.00 to $78.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Silgan (NYSE:SLGN) had its target price cut by JPMorgan Chase & Co. from $53.00 to $47.00. They currently have an overweight rating on the stock.

Tenable (NASDAQ:TENB) had its target price lowered by Canaccord Genuity Group Inc. from $33.00 to $28.00. They currently have a buy rating on the stock.

Teva Pharmaceutical Industries (NYSE:TEVA) had its target price raised by JPMorgan Chase & Co. from $35.00 to $40.00. The firm currently has an overweight rating on the stock.

U.S. Bancorp (NYSE:USB) had its price target reduced by JPMorgan Chase & Co. from $58.00 to $57.50. They currently have an underweight rating on the stock.

Verisk Analytics (NASDAQ:VRSK) had its price target boosted by JPMorgan Chase & Co. from $220.00 to $230.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Vistra (NYSE:VST) had its target price reduced by JPMorgan Chase & Co. from $240.00 to $231.00. They currently have an overweight rating on the stock.

Verizon Communications (NYSE:VZ) had its price target increased by JPMorgan Chase & Co. from $49.00 to $52.00. The firm currently has a neutral rating on the stock.

Wayfair (NYSE:W) had its target price cut by Jefferies Financial Group Inc. from $86.00 to $70.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.

Waystar (NASDAQ:WAY) had its price target cut by JPMorgan Chase & Co. from $40.00 to $38.00. The firm currently has an overweight rating on the stock.

Wells Fargo & Company (NYSE:WFC) had its price target lowered by JPMorgan Chase & Co. from $91.00 to $86.50. JPMorgan Chase & Co. currently has a neutral rating on the stock.

WAVE Life Sciences (NASDAQ:WVE) had its target price trimmed by Canaccord Genuity Group Inc. from $52.00 to $43.00. The firm currently has a buy rating on the stock.